NuGen Medical Devices Inc. Provides Update on Health Canada License

Toronto, Ontario–(Newsfile Corp. – February 5, 2026) – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company“) is initiating a temporary halt on its devices in Canada due to the lapse of its license with Health Canada.

The Company’s Health Canada Licence became expired due to an untimely certificate renewal. This is not a suspension or cancellation related to regulatory compliance or enforcement action. The temporary status does not constitute a product safety risk. However, to remain compliant with Health Canada medical device regulations, NuGen is currently not selling the affected devices in Canada.

A new licence application has already been submitted, and NuGen has been in active communication with Health Canada throughout the process. NuGen is confident the licence will be renewed soon, and sales will resume once the new licence becomes available. The Company’s operations elsewhere in the world remain unaffected. The Company will continue to provide updates when available.

About NuGen Medical Devices

NuGen develops next-generation needle-free devices for subcutaneous drug delivery. Its flagship InsuJet™ system is approved in 42 countries and is designed to improve the lives of millions of people with diabetes worldwide.

Websites: insujet.com | insujet.fr | nugenmd.com

LinkedIn: https://www.linkedin.com/company/nugen-medical-devices

Investor Relations: [email protected]

Notice Regarding Forward-Looking Information:

Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282935